{
 "drug": "Benztropine Mesylate Injection",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "01/27/2026",
 "dayN": 210,
 "cat": "Neurology",
 "companies": [
  "Fresenius Kabi USA, LLC"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "01/27/2026",
   "update_type": "New",
   "initial_posting_date": "01/27/2026",
   "package_ndc": "63323-970-02",
   "generic_name": "Benztropine Mesylate Injection",
   "contact_info": "888-386-1300",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA090233"
    ],
    "brand_name": [
     "BENZTROPINE MESYLATE"
    ],
    "generic_name": [
     "BENZTROPINE MESYLATE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-970"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "BENZTROPINE MESYLATE"
    ],
    "rxcui": [
     "885205"
    ],
    "spl_id": [
     "11222231-55b1-48ee-a8f8-3385f1a2eb36"
    ],
    "spl_set_id": [
     "b03bd28e-3b44-41e4-9a7e-28b9d7975245"
    ],
    "package_ndc": [
     "63323-970-02"
    ],
    "unii": [
     "WMJ8TL7510"
    ]
   },
   "update_date": "01/27/2026",
   "therapeutic_category": [
    "Neurology"
   ],
   "dosage_form": "Injection",
   "presentation": "Benztropine Mesylate, Injection, 1 mg/1 mL (NDC 63323-970-02)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "To Be Discontinued"
  }
 ]
}